Hipgnosis Songs Fund Ltd on Thursday kicked off a strategic review as it looks to win back investor confidence after pulling its payout, ahead of key votes on its future next week.

Shares in the company rose 1.6% to 74.25 pence each in London on Thursday morning, but are down roughly 14% year-to-date.

Among the things the music intellectual property rights investor will consider are ‘future management arrangements of the company’.

It ruled out ‘any offer for the company, recommended or otherwise’.

Hipgnosis said it has begun the process of identifying a new chair, appointing an executive search firm. It is currently chaired by Andrew Sutch.

The decision to undertake the strategic review followed ‘extensive engagement over recent weeks with shareholders’.

‘These meetings highlighted a continued belief in the company’s portfolio and growth prospects of the asset class as well as the need for changes by the company in order to deliver value for shareholders,’ the firm said.

On Monday, Hipgnosis pulled a previously declared interim dividend. Hipgnosis said it now expects to receive ‘significantly lower retroactive payments’ of songwriter royalties for 2018 to 2022. Due to the expected decision by the US Copyright Royalty Board for that period, Hipgnosis plans to reduce its retroactive accrual to $9.9 million from the $21.7 million it had accrued at the end of March.

The decision came ahead of the company’s annual general meeting this time next week, which will see shareholders vote on two key motions, a planned disposal and the company’s continuation.

In September, Hipgnosis said it is selling off 29 of its music catalogues for $440 million to help fund a share buyback programme and reduce its debt.

It is selling off the catalogues to Hipgnosis Songs Capital, which is a partnership between HSF’s investment adviser Hipgnosis Song Management Ltd and funds advised by New York-based alternative asset manager Blackstone Inc.

There will also be a continuation vote next week. If its continuation is supported, shareholders would next have a continuation vote at an extraordinary general meeting in January 2026, another at the AGM in 2028 and then at every third AGM thereafter.

The company said on Thursday: ‘The board continues to recommend voting in favour of the continuation resolution, believing it is in shareholders’ interest to have a strategic review with the widest array of options for the company to consider and to identify changes that will focus on recovering and delivering improved shareholder value. In addition, the board continues to recommend voting in favour of the first disposal resolution in order to realise proceeds to reduce leverage and undertake a share buyback, and notes that the go-shop process to seek a potential superior offer remains ongoing.’

Asset Value Investors, which manages London-listed AVI Global Trust PLC, on Monday said a ‘reset’ is needed at Hipgnosis. Asset Value Investors manages a 5% stake in Hipgnosis.

Asset Value Investors encouraged shareholders to vote against the disposal and continuation.

‘Over the course of the last several weeks, we have spoken with a majority of the share register. Not one of those shareholders is in favour of an immediate sale of the portfolio, yet we believe many will vote against continuation. We urge undecided shareholders not to be swayed by a misleading narrative that a failure to pass the continuation resolution results in a wind up of the company or a fire sale of assets,’ Asset Value Investors said on Monday.

‘Voting against continuation should not be perceived as a negative stance to take. On the contrary, we remain excited by the prospects for the company’s asset.’

It continued: ‘The company has a bright future. And that may well be with the current manager on revised terms should a new board decide so following consultation with shareholders. But we do, however, strongly believe that a reset is urgently required.’

HSF has previously said that if its continuation is not passed, it would be ‘required to put forward proposals for the reconstruction, reorganisation or winding-up of the company to the shareholders for their approval within six months’.

Asset Value Investors earlier this week said that should not be interpreted as a fire sale of HSF assets.

‘We note the six-month period is a standard clause for closed-end funds with continuation votes. It exists to protect shareholders, not to create a deadline which in any way compromises their best interests, and it could quite easily be extended with the consent of shareholders,’ Asset Value Investors explained on Monday.

‘[HSF] now trades on a discount to NAV in excess of 50%. It is imperative that the focus now is on addressing all impediments to the shares trading closer to fair value. Voting against continuation would provide a newly reconstituted board with a blank canvas to take on this task. We understand the manager has recently bolstered its team with new hires including a new CFO and general counsel, which we welcome. This should serve them well if the refreshed board decides to ask the Manager to re-pitch for their role in a beauty parade of potential new managers.’

Asset Value Investors said it is looking for answers from HSF in respect to the pulled dividend. It noted HSF shares have already gone ex-dividend, a cut-off date which means new investors would not qualify for the latest payout.

Asset Value Investors said: ‘We are seeking urgent clarification from the company on certain matters in relation to this announcement. This raises yet more questions around the way in which our company is being managed, and we expect shareholders will take this latest development into account when casting their votes at the upcoming meetings.’

Copyright 2023 Alliance News Ltd. All Rights Reserved.